Ioanna Tsiligianni - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Ioanna Tsiligianni's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Ioanna Tsiligianni

Ioanna Tsiligianni

Verified

Editor-in-Chief, Primary Care Respiratory Medicine

Final Covers

LGBTQIA+ culture feminismSocial issues health and mental health.

Journalist Type

-

Seniority Positions

Medium Formats

-

Content

Total articles 32

  • Optimal Pathways to Lung Cancer Screening in Primary Care Settings: A Scoping Review

    By Ioanna Tsiligianni| MDPI@ 1. IntroductionLung cancer remains one of the leading causes of cancer-related morbidity and mortality worldwide, with nearly 2.5 million new cases and over 1.8 million deaths globally [1]. While there have been notable advancements in managing early- and advanced-stage lung cancer, the level of improved outcomes achieved in other cancer types over the past four decades has not been attained [2].

    By Ioanna Tsiligianni · MDPI

    Dec. 26, 2024

  • Improving GPs’ Emotional Intelligence and Resilience to Better Manage Chronic Respiratory Diseases Through an Experiential Online Training Intervention: A Mixed Methods Study

    By Ioanna Tsiligianni| MDPI@ Conclusions: These findings underscore the importance of integrating EI and resilience training into medical education and professional development programs. Such initiatives could effectively support the emotional and psychological needs of PCPs and potentially contribute to an improved quality of care for patients with CRDs. 1.

    By Ioanna Tsiligianni · MDPI

    Dec. 25, 2024

  • Optimal Pathways to Lung Cancer Screening in Primary Care Settings: A Scoping Review

    By Ioanna Tsiligianni| MDPI@ 1. IntroductionLung cancer remains one of the leading causes of cancer-related morbidity and mortality worldwide, with nearly 2.5 million new cases and over 1.8 million deaths globally [1]. While there have been notable advancements in managing early- and advanced-stage lung cancer, the level of improved outcomes achieved in other cancer types over the past four decades has not been attained [2].

    By Ioanna Tsiligianni · MDPI

    Dec. 26, 2024

As seen in

Company Info

Primary Care Respiratory Medicine

Greece

+30 281 039 4300